U.S. News & World Report named our Diabetes and Endocrinology Program among the top 10 in the nation.
Children’s National is home to one of the largest pediatric diabetes program in the Mid-Atlantic region, providing care for children and young adults from Washington, D.C., Virginia and Maryland. With our extensive expertise in the long-term care of children and adolescents with Type 1 and Type 2 diabetes, we will equip you and your child with the best resources and education to successfully manage this chronic condition.
At Children’s National, we provide a full range of services for our patients living with diabetes. Our team of experts is with you from your child’s initial diagnosis through treatment and follow-up care. We take time to explain the diagnosis, maintain regular appointments and identify healthy habits and behaviors that will contribute to your child’s quality of life.
Highlights of our program include:
At Children’s National we understand the benefit of keeping parents informed. We have expert advice on how you can help your child with diabetes maintain a normal life.
The Capital Area Food Bank and Children’s National Hospital offer children with prediabetes and diabetes who are experiencing food insecurity to leave their visits with nutritious groceries from an on-site “food pharmacy.”
For more information or to make an appointment with our care team, call 202-476-3440. If your child is a new visitor, please bring your child’s latest lab work to their doctor’s visit. If your child is currently a patient at Children’s National, please bring their blood glucose meters and data from pumps and continuous glucose monitoring devices to their doctor’s visit.
For the Bassler family, this past spring was filled with big changes and new learnings about type 1 diabetes. For Lakin, it was about learning to live with her disease.
Director, Childhood and Adolescent Diabetes ProgramDiabetologist
Division Chief, Endocrinology Program Director, Endocrinology Fellowship
Director, Type 2 Diabetes ProgramEndocrinologist
Roopa Kanakatti Shankar
Associate Director, Childhood and Adolescent Diabetes ProgramEndocrinologist
Associate Director, Endocrinology FellowshipEndocrinologist
Director, Thyroid Nodule and Cancer Program Associate Director, Endocrinology FellowshipEndocrinologist
Director, Endocrine and Diabetes Clinical Psychology Services Psychologist
A device known as a bionic pancreas, which uses next-generation technology to automatically deliver insulin, was more effective at maintaining blood glucose levels within normal range than standard-of-care management among people with Type 1 diabetes, a new multicenter clinical trial has found. The trial, conducted partly at Children’s National Hospital was primarily funded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), part of the National Institutes of Health, and published in the New England Journal of Medicine.